Amgen Confirms US Aflibercept Filing As Regeneron Awaits Biocon Trial Fate

Key Exclusivity In May 2024, But Feeling Is That H2 2025 Launch More Likely

 
• By Dean Rudge
perfect blue eye macro in a sterile environment and perfect vision in resolution 6k, concept, the vision of the future and healthy life concept. view precise and straight to the target.
• Source: Shutterstock

More from Biosimilars

More from Products